Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract.
BACKGROUND
The limited ability of current treatments to control metastasis and the proposed antitumor properties of specific nutrients prompted us to examine the effect of a specific formulation (nutrient supplement [NS]) of lysine, proline, arginine, ascorbic acid, and green tea extract in vivo on the development of N-methyl-N-nitrosourea (MNU)-induced mammary tumors in rats.


METHODS
A single intraperitoneal dose of MNU was injected into each of 20 female Sprague-Dawley rats (aged 50 days) to induce tumors. Two weeks after MNU treatment, a time by which the animals had recovered from MNU-induced toxicity, the rats were divided into two groups. Rats in group 1 (n = 10) were fed Purina chow diet, whereas those in group 2 (n = 10) were fed the same diet supplemented with 0.5% NS. After a further 24 weeks, the rats were killed and tumors were excised and processed.


RESULTS
NS reduced the incidence of MNU-induced mammary tumors and the number of tumors by 68.4%, and the tumor burden by 60.5%. The inhibitory effect of NS was also reflected by decreased tumor weight; the tumor weights per rat and per group were decreased by 41% and 78%, respectively. In addition, 30% of the control rats developed ulcerated tumors, in contrast to 10% in the nutrient supplemented rats.


CONCLUSIONS
These findings suggest that the specific formulation of lysine, proline, arginine, ascorbic acid, and green tea extract tested significantly reduces the incidence and growth of MNU-induced mammary tumors, and therefore has strong potential as a useful therapeutic regimen for inhibiting breast cancer development.
Matthias Rath Research, Cancer Division, Santa Clara, California, USA. m.roomi@drrath.com
M Waheed
MW
Roomi
Nusrath W
NW
Roomi
Vadim
V
Ivanov
Tatiana
T
Kalinovsky
Aleksandra
A
Niedzwiecki
Matthias
M
Rath
D000477:Alkylating Agents / Q000633:toxicity; D000821:Animal Feed; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001120:Arginine / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D018890:Chemoprevention; D005260:Female; D007274:Injections, Intraperitoneal; D008239:Lysine / Q000494:pharmacology; D015674:Mammary Neoplasms, Animal / Q000517:prevention & control*; D008770:Methylnitrosourea / Q000633:toxicity; D009374:Neoplasms, Experimental; D011392:Proline / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013662:Tea
D000477:Alkylating Agents; D000975:Antioxidants; D013662:Tea; D008770:Methylnitrosourea; D001120:Arginine; D011392:Proline; D008239:Lysine; D001205:Ascorbic Acid